Price target
14.25RUSD+10.41+271.09%
The 4 analysts offering 1 year price forecasts for Cardiff Oncology, Inc. have a max estimate of 20.00 and a min estimate of 10.00.
Analyst rating
Based on 6 analysts giving stock ratings to Cardiff Oncology, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
6
Buy
0
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.32
−0.24
−0.16
−0.08
0.00
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.25
−0.22
−0.21
−0.22
−0.26
−0.25
−0.22
—
—
—
—
Estimate
−0.26
−0.28
−0.27
−0.25
−0.25
−0.27
−0.25
−0.19
−0.20
−0.20
−0.21
Surprise
+4.13%
+22.54%
+21.36%
+11.46%
−5.05%
+7.22%
+10.70%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
60.00 K
120.00 K
180.00 K
240.00 K
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
108.00 K
141.00 K
156.00 K
205.00 K
163.00 K
165.00 K
153.00 K
—
—
—
—
Estimate
50.00 K
50.00 K
50.00 K
62.50 K
58.75 K
70.00 K
100.00 K
91.67 K
91.67 K
91.67 K
91.67 K
Surprise
+116.00%
+182.00%
+212.00%
+228.00%
+177.45%
+135.71%
+53.00%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CRDF EPS for the last quarter is −0.22 USD despite the estimation of −0.25 USD. In the next quarter EPS is expected to reach −0.19 USD. Track more of Cardiff Oncology, Inc. financials and stay on top of what is up with the company.
In the next quarter Cardiff Oncology, Inc. revenue is expected to reach 91.67 K USD. Check out Cardiff Oncology, Inc. revenue and earnings and make informed decisions.
According to analysts, CRDF price target is 14.25 USD with a max estimate of 20.00 USD and a min estimate of 10.00 USD. Check if this forecast comes true in a year, meanwhile watch Cardiff Oncology, Inc. stock price chart and keep track of the current situation with CRDF news and stock market news.
We've gathered opinions of 6 analysts rating CRDF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.